department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Calcitonin-Salmon · pharmadog

pharmadog
drugs
Calcitonin-Salmon

drug

patient view →

calcitonin

Marketedupdated 2mo ago

by Par Pharmaceutical Inc

Approved

community read0 votes

Protein drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 2 investigational indications.

all catalysts(1)

approval · 1

CALCITONIN-SALMON (CALCITONIN SALMON) — FDA approval

News(0)

no news has mentioned this drug yet

brand

Calcitonin-Salmon

generic

calcitonin

MOA

12.1 Mechanism of Action Calcitonin salmon is a calcitonin receptor agonist. Calcitonin salmon acts primarily on bone, but direct renal effects and actions on the gastrointestinal tract are also recognized. Calcitonin salmon appears to have actions essentially identical to calcitonins of mammalian origin, but its potency per mg is greater and it has a longer duration of action. The actions of calcitonin on bone and its role in normal human bone physiology are still not completely elucidated, although calcitonin receptors have been discovered in osteoclasts and osteoblasts.

indication

Post Menopausal Osteoporosis

phase

marketed

$AMRX16.92-1.34%

Data sources

openFDA · ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 2

tagApproval8 co-mentions · 2 sources
drugCALCITONIN-SALMON8 co-mentions · 2 sources

Trials studying calcitonin

N/AAlpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritisrecruitingn=442
N/APROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCTcompletedn=700
N/AEvaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Departmentcompletedn=200
—DetectIon of Severe Sepsis In PATients With Neurological haemorrhagE (The DISSIPATE Study)unknownn=150